CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

Clinical trial NCT06347718 · RECRUITING

Trial details

NCT number: NCT06347718
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Systemic Sclerosis Dermatomyositis Polymyositis

Start date: 2023-07-17
Primary completion: 2026-05-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.